In the US, Pegvisomant (pegvisomant systemic) is a member of the drug class growth hormone receptor blockers and is used to treat Acromegaly.
US matches:
- Pegvisomant
- Pegvisomant Subcutaneous
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
H01AX01
CAS registry number (Chemical Abstracts Service)
0218620-50-9
Chemical Formula
C990-H1532-N262-O300-S7
Molecular Weight
22129
Therapeutic Categories
Anterior pituitary hormone
Growth hormone receptor antagonist
Chemical Names
18-L-aspartic acid-21-L-asparagine-120-L-lysine-167-L-asparagine-168-L-alanine-171-L-serine-172-L-arginine-174-L-serine-179-L-threonine growth hormone (human), reaction product with polyethylene glycol
PEGylated human growth hormone (IUPAC)
Foreign Names
- Pegvisomantum (Latin)
- Pegvisomant (German)
- Pegvisomant (French)
- Pegvisomant (Spanish)
Generic Names
- Pegvisomant (OS: USAN)
- B 2036-PEG (IS: Sensus)
- G 120K-PEG (IS: Sensus)
- Pegylated human growth hormone mutein (IS)
Brand Names
- Somavert
Pfizer, Argentina; Pfizer, Belgium; Pfizer, Bulgaria; Pfizer, Canada; Pfizer, Switzerland; Pfizer, Czech Republic; Pfizer, Germany; Pfizer, Denmark; Pfizer, Spain; Pfizer, Finland; Pfizer, France; Pfizer, United Kingdom; Pfizer, Croatia (Hrvatska); Pfizer, Hungary; Pfizer, Ireland; Pfizer, Israel; Pfizer, Iceland; Pfizer, Italy; Pfizer, Japan; Pfizer, Luxembourg; Pfizer, Mexico; Pfizer, Netherlands; Pfizer, Norway; Pfizer, Portugal; Pfizer, Serbia; Pfizer, Sweden; Pfizer, Slovenia; Pfizer, Slovakia; Pfizer, United States; Pfizer Limited, Austria
International Drug Name Search
Glossary
| IUPAC | International Union of Pure and Applied Chemistry |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment